Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Alliance Pharma Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Alliance Pharma's earnings have been declining at an average annual rate of -67.2%, while the Pharmaceuticals industry saw earnings declining at 2.4% annually. Revenues have been growing at an average rate of 7.8% per year.
Anahtar bilgiler
-67.2%
Kazanç büyüme oranı
-67.3%
EPS büyüme oranı
Pharmaceuticals Sektör Büyümesi | 14.1% |
Gelir büyüme oranı | 7.8% |
Özkaynak getirisi | -15.1% |
Net Marj | -18.3% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues
Sep 10Is Alliance Pharma (LON:APH) A Risky Investment?
Jun 21Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet
Feb 23Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)
Nov 21We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt
May 26Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models
Mar 24We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt
Sep 30An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued
May 28Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet
Mar 30Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?
Dec 24Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?
Nov 19Gelir ve Gider Dağılımı
Alliance Pharma nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 183 | -34 | 56 | 0 |
31 Mar 24 | 182 | -33 | 55 | 0 |
31 Dec 23 | 181 | -33 | 53 | 0 |
30 Sep 23 | 175 | -31 | 59 | 0 |
30 Jun 23 | 170 | -29 | 64 | 0 |
31 Mar 23 | 169 | -25 | 64 | 0 |
31 Dec 22 | 167 | -21 | 64 | 0 |
30 Sep 22 | 165 | -5 | 63 | 0 |
30 Jun 22 | 163 | 12 | 62 | 0 |
31 Mar 22 | 163 | 10 | 62 | 0 |
31 Dec 21 | 163 | 7 | 62 | 0 |
30 Sep 21 | 155 | 13 | 59 | 0 |
30 Jun 21 | 147 | 18 | 55 | 0 |
31 Mar 21 | 138 | 13 | 50 | 0 |
31 Dec 20 | 130 | 8 | 46 | 0 |
30 Sep 20 | 131 | 10 | 46 | 0 |
30 Jun 20 | 131 | 11 | 46 | 0 |
31 Mar 20 | 133 | 18 | 47 | 0 |
31 Dec 19 | 136 | 25 | 48 | 0 |
30 Sep 19 | 133 | 23 | 48 | 0 |
30 Jun 19 | 130 | 21 | 48 | 0 |
31 Mar 19 | 124 | 20 | 46 | 0 |
31 Dec 18 | 118 | 18 | 44 | 0 |
30 Sep 18 | 112 | 21 | 40 | 0 |
30 Jun 18 | 107 | 24 | 36 | 0 |
31 Mar 18 | 104 | 27 | 35 | 0 |
31 Dec 17 | 102 | 29 | 33 | 0 |
30 Sep 17 | 101 | 25 | 33 | 0 |
30 Jun 17 | 100 | 22 | 32 | 0 |
31 Mar 17 | 99 | 20 | 31 | 0 |
31 Dec 16 | 97 | 18 | 30 | 0 |
30 Sep 16 | 85 | 18 | 26 | 0 |
30 Jun 16 | 72 | 18 | 22 | 0 |
31 Mar 16 | 60 | 15 | 19 | 0 |
31 Dec 15 | 48 | 13 | 16 | 0 |
30 Sep 15 | 47 | 11 | 16 | 0 |
30 Jun 15 | 45 | 8 | 15 | 0 |
31 Mar 15 | 44 | 8 | 14 | 0 |
31 Dec 14 | 44 | 8 | 13 | 0 |
30 Sep 14 | 44 | 8 | 13 | 0 |
30 Jun 14 | 44 | 9 | 13 | 0 |
31 Mar 14 | 45 | 9 | 13 | 0 |
31 Dec 13 | 45 | 10 | 14 | 0 |
Kaliteli Kazançlar: APH is currently unprofitable.
Büyüyen Kar Marjı: APH is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: APH is unprofitable, and losses have increased over the past 5 years at a rate of 67.2% per year.
Büyüme Hızlandırma: Unable to compare APH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: APH is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (4.5%).
Özkaynak Getirisi
Yüksek ROE: APH has a negative Return on Equity (-15.07%), as it is currently unprofitable.